The "The Corporate Reputation of Pharma, 2017 - The Patient Perspective - Asia Edition" report has been added to ResearchAndMarkets.com's offering.
Introducing the results of the 2017 (2nd) edition of The Corporate Reputation of Pharma - from the Perspective of Asian Patient Groups. In total, 101 Asian patient groups from across the region participated in the 2017 survey (with 35% of the respondents being based in Australasia).
Asian patient groups (and the patients they represent), on the whole, take a more positive view of the pharmaceutical industry than patient groups from elsewhere in the world. As many as 51% of the respondent Asian patient groups stated that the pharmaceutical industry as a whole had an Excellent or Good corporate reputation in 2017 (on a par with the 50% of Asian patient groups saying the same in 2016). The equivalent figure from patient groups worldwide in 2017 was 43%.
Companies Featured
Key Topics Covered
For more information about this report visit https://www.researchandmarkets.com/research/n3th2c/the_corporate?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181113005918/en/
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Pharmaceuticals